戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 erall structure and directly binds to CoA or short-chain acyl-CoA derivatives to form a homotetramer
2 talyze acylations on histones in vitro using short-chain acyl-CoA donors, proving that they are less
3 yridine dinucleotides (NAD(+) and NADH), and short-chain acyl-CoAs (acetyl, malonyl, succinyl, and pr
4 the simultaneous analysis of nucleotides and short-chain acyl-CoAs.
5                         Urea, ornithine, and short-chain acylcarnitines were decreased in GCTs.
6  the effects of two representative long- and short-chain AHLs, N-3-(oxododecanoyl)-homoserine lactone
7 se II (SCRII) from Candida parapsilosis is a short-chain alcohol dehydrogenase/reductase.
8 proved Tms and product yields of eight other short-chain alcohol dehydrogenases/reductases.
9 hird polymer component, which represents the short-chain alcohol.
10 nmental stresses, such as cold temperatures, short chain alcohols, and high magnesium concentrations.
11                                        Other short-chain alcohols followed a similar pattern.
12  inhibition when exposed to ethanol or other short-chain alcohols or when incubated at modestly reduc
13                           We discovered that short-chain aldehydes bind in an inverted fashion compar
14 iridines were produced by oligomerization of short-chain aldehydes in the presence of ammonia.
15                             STRs also accept short-chain aliphatic aldehydes to give enantioenriched
16 emase, two D-gluconate 2-epimerases, and one short-chain aliphatic alpha-hydroxyacid racemase among t
17 o methanogenic, anaerobic methanotrophic and short-chain alkane-oxidizing archaea, and propose a poss
18 l methanogenic, anaerobic methanotrophic and short-chain alkane-oxidizing archaea.
19 aracterized type of methanogenesis linked to short-chain alkane/fatty acid oxidation in a previously
20 g the ability of PRM to degrade a variety of short-chain alkanes and ethene in addition to dioxane, u
21 d by the symbiotic Cycloclasticus to degrade short-chain alkanes and those of free-living Cycloclasti
22 also pave the way to selective production of short-chain alkanes from waste carboxylic acids under mi
23                                  Analyses of short-chain alkanes in the environment of the Campeche K
24 stead, these symbionts use propane and other short-chain alkanes such as ethane and butane as carbon
25            The fastest-growing bacteria used short-chain alkanes.
26 portion of amylose at the expense of reduced short-chain amylopectin.
27 mulation and trophic transfer of 14 PFASs (5 short-chain and 9 long-chain) within the food web of the
28               Activities on hPXR for several short-chain and alternative PFAS compounds to long-chain
29                                        These short-chain and alternative species include perfluorobut
30 l toxicity, prompting their replacement with short-chain and fluoroether compounds.
31 for example, short chain branching (SCB) and short chain branch distribution (SCBD), have a direct im
32     Polyolefin microstructures, for example, short chain branching (SCB) and short chain branch distr
33 calorimetric studies of their complexes with short-chain carboxylates.
34 ich can be anaerobically digested to produce short-chain carboxylic acids.
35                  A methyl 2-oxoester, with a short chain carrying a naphthalene ring, was found to pr
36                   Accurate quantification of short-chain chlorinated paraffins (SCCPs) poses an excep
37 OF method for simultaneous quantification of short-chain chlorinated paraffins (SCCPs, C10-13) and an
38     This pathway documents the presence of a short-chain cis-prenyl diphosphate synthase, previously
39                                            A short-chain cis-prenyl transferase (LfCPT1) first produc
40 ocus on collagen IV and its variant, spongin short-chain collagens, of non-bilaterian animal phyla.
41   Although they belong to the superfamily of short chain dehydrogenase-reductases, the epimerase-acti
42 aldo-keto reductase and previously annotated short chain dehydrogenase/reductase, respectively, in Cl
43                                          The short-chain dehydrogenase-related protein Ayr1 forms an
44         A bpss2242 gene, encoding a putative short-chain dehydrogenase/oxidoreductase (SDR) in Burkho
45  gene is predicted to encode a member of the short-chain dehydrogenase/reductase (SDR) superfamily, b
46 two murine epidermal retinol dehydrogenases, short-chain dehydrogenase/reductase family 16C member 5
47 nded N terminus was also observed in several short-chain dehydrogenase/reductase family members.
48  NAD(+)-dependent epimerase belonging to the short-chain dehydrogenase/reductase family.
49                 Interestingly, mycobacterial short chain dehydrogenases/reductases (SDRs) within fami
50 entified and characterized two P trichocarpa short-chain dehydrogenases, PtPAR1 and PtPAR2, which wer
51 sification as belonging to a novel family of short-chain dehydrogenases.
52 ntified and functionally characterized three short-chain dehydrogenases/reductases (SDRs) NV10127, NV
53 ken together, these results demonstrate that short-chain diamines are common substrates for the PACE
54  aceI gene is induced in A. baumannii by the short-chain diamines cadaverine and putrescine.
55 howed that AceI mediates the efflux of these short-chain diamines when energized by an electrochemica
56                    Higher baseline levels of short-chain dicarboxylacylcarnitine metabolite 3-hydroxy
57                                              Short-chain dicarboxylacylcarnitine metabolites and aspa
58 d medium particle size (HMSP), GlycA, LP-IR, short-chain dicarboxylacylcarnitines (SCDA), and branche
59 s in long-chain acylarnitine metabolites and short-chain dicarboxylacylcarnitines correlated with inc
60  = .01 and .03, respectively), and increased short-chain dicarboxylacylcarnitines glutaryl carnitine,
61                                              Short-chain FA-VOCs (C5 and C6) are among the most abund
62 IP8, that is associated with accumulation of short-chain FA-VOCs in tomato fruit.
63 ant had much lower content of multiple fruit short-chain FA-VOCs, validating an important role for th
64 tant early step in the synthesis of multiple short-chain FA-VOCs.
65 -derived citrate or by acetyl-CoA synthetase short-chain family member 2 (ACSS2) from acetate.
66                                       Faecal short chain fatty acid (SCFA) and urinary volatile organ
67 erative colitis and sodium butyrate (NaB), a short chain fatty acid (SCFA) normally produced in the i
68 terial community, stool microRNA (miRNA) and short chain fatty acid (SCFA) signatures to correlate th
69 acidifying the proximal colon and triggering short chain fatty acid (SCFA)-mediated intracellular aci
70 and acetogens may be a significant factor in short chain fatty acid formation in the colon contributi
71 evealed no significant difference in gas and short chain fatty acid level among substrates evaluated.
72 o differences in gut microbiota diversity or short chain fatty acid production across time or with di
73 ed by gut microbes, increasing production of short chain fatty acids (mainly acetate and lactate) and
74                                              Short chain fatty acids (SCFA) are metabolites of intest
75 , plasma and muscle biochemistry, intestinal short chain fatty acids (SCFA), and liver glycogen of tr
76 ion, freeze-drying caused a relative loss of short chain fatty acids (SCFA).
77 the induction of T regulatory cells, and the short chain fatty acids (SCFAs) butyrate, propionate and
78  cytokines and an increase in IgA levels and short chain fatty acids (SCFAs) in both trachea and lung
79 pecially with no study of gut microbiota and short chain fatty acids (SCFAs) in nephrolithiasis.
80 ticle, we demonstrate that dietary fiber and short chain fatty acids (SCFAs) induced the expression o
81 g bacteria, which ferment dietary fiber into short chain fatty acids (SCFAs) known to be important fo
82                                        Fecal short chain fatty acids (SCFAs) were measured using a li
83                                              Short chain fatty acids (SCFAs; e.g., acetate, propionat
84                                         Both short chain fatty acids and C. acnes culture supernatant
85 a, a commensal bacterial genus that produces short chain fatty acids and endotoxins, each of which ma
86                   Mass spectrometry measured short chain fatty acids and functional prediction from 1
87 or 2 in which Gi-mediated signalling by both short chain fatty acids and synthetic agonists was maint
88 uman acyl-ACP substrate and readily releases short chain fatty acids from full-length FASN during tur
89 ry activity exhibited chemical properties of short chain fatty acids known to be produced from C. acn
90 Y-FL-pentanoic-acid staining revealed higher short chain fatty acids levels in the intestine of treat
91 crobial organophosphate degradation produces short chain fatty acids like acetic acid, which induces
92 beneficial to the host and demonstrates that short chain fatty acids may be useful to limit formation
93 ration of 3-indolepropionic acid, serotonin, short chain fatty acids or tauroursodeoxycholic acid sho
94 Fatty Acid Receptor 2 is a GPCR activated by short chain fatty acids produced in high levels in the l
95                     The addition of the pure short chain fatty acids propionic, isobutyric or isovale
96 S to generate acetate and propionate as main short chain fatty acids.
97 Fermentation end products, in particular the short-chain fatty acid (SCFA) acetate, are believed to b
98 igated the effect of Propionic acid (PPA), a short-chain fatty acid (SCFA) and a product of dys-bioti
99 notyping, gut metagenomic sequence and fecal short-chain fatty acid (SCFA) levels were available(2),
100 P < 0.0001), stool frequency (P = 0.02), and short-chain fatty acid (SCFA) producer Lachnospira [fals
101 d comparative analyses of gut microbiota and short-chain fatty acid (SCFA) profiles across different
102                                          The short-chain fatty acid (SCFA) receptor FFAR3 was found t
103                                              Short-chain fatty acid (SCFA) species altered after anti
104            Sodium butyrate (NaBu), a form of short-chain fatty acid (SCFA), acts classically as a pot
105 s and diversity, depletion of anaerobes, and short-chain fatty acid (SCFA)-producing bacteria, and an
106 ion by 16 S rRNA amplicon sequencing and for short-chain fatty acid (SFCA) analysis.
107 high-fiber diet and supplementation with the short-chain fatty acid acetate on the gut microbiota and
108 e impact of a microbiota-derived metabolite, short-chain fatty acid acetate, on an acute mouse model
109  main metabolites of the gut microbiota, the short-chain fatty acid acetate.
110  high-fiber diet or supplementation with the short-chain fatty acid acetate.
111 ission after FMT and had increased levels of short-chain fatty acid biosynthesis and secondary bile a
112 ation between an increase in the circulating short-chain fatty acid butyrate and pain improvement fol
113                                    Regarding short-chain fatty acid concentrations, prebiotic adminis
114 re observed in stool frequency or form or in short-chain fatty acid concentrations.
115 ography-mass spectroscopy was used to assess short-chain fatty acid concentrations.
116 ssociated with significantly decreased cecal short-chain fatty acid concentrations.
117 cronutrient intake, stool diaries, and fecal short-chain fatty acid concentrations.Patients were rand
118 odelling indicate that Rv2509 belongs to the short-chain fatty acid dehydrogenase/reductase (SDR) fam
119 when cultured with butyric acid, a principal short-chain fatty acid in the fermentation metabolites o
120 ociated with EAE susceptibility, implicating short-chain fatty acid metabolism as a key element conse
121 tions included involvement of amino acid and short-chain fatty acid metabolism pathways.
122                                            A short-chain fatty acid olfactory receptor Olfr78, recent
123                                Butyrate is a short-chain fatty acid produced by the intestinal bacter
124 in asymptomatic are enriched in pathways for short-chain fatty acid production.
125                                          The short-chain fatty acid profile contributed by dominant g
126 on node highlighted by the expression of the short-chain fatty acid receptor FFAR3.
127 opulation distinguished by expression of the short-chain fatty acid receptor free fatty acid receptor
128 Depletion of CD25(+) Tregs or absence of the short-chain fatty acid receptor GPR43 abolished this sur
129  detected and included reduced abundances of short-chain fatty acid-producing bacteria in Canadian HE
130 es identified a significant reduction in the short-chain fatty acid-producing taxonomies Akkermansia,
131 r without addition of gut metabolites called short-chain fatty acids ([SCFA)] produced during ferment
132                   Reduced fecal excretion of short-chain fatty acids (including butyrate, propionate,
133 ncrease 1.3 +/- 0.5 vs 0.9 +/- 0.6), and the short-chain fatty acids (mumol/g) acetate (decrease 27.4
134                                              Short-chain fatty acids (SCFA), formed by microbial ferm
135 ts dietary non-digestible carbohydrates into short-chain fatty acids (SCFA).
136 tine, along with lower levels of circulating short-chain fatty acids (SCFA).
137           Microbiota-generated fiber-derived short-chain fatty acids (SCFAs) and free fatty acid rece
138 se metabolism, gut hormones, gut microbiota, short-chain fatty acids (SCFAs) and metabolites.
139 if they can support methane bioconversion to short-chain fatty acids (SCFAs) and the associated micro
140                              KEY POINTS: The short-chain fatty acids (SCFAs) are bacterial metabolite
141                                              Short-chain fatty acids (SCFAs) are fermented dietary co
142                                              Short-chain fatty acids (SCFAs) are metabolites present
143                                              Short-chain fatty acids (SCFAs) are produced from dietar
144                                              Short-chain fatty acids (SCFAs) are small molecules ubiq
145                                              Short-chain fatty acids (SCFAs) butyrate and propionate
146 weeks of treatment, PLPE increased levels of short-chain fatty acids (SCFAs) by enhancing abundance o
147 of the gut microbiota, and faecal and plasma short-chain fatty acids (SCFAs) determination.
148                                              Short-chain fatty acids (SCFAs) have immunomodulatory ef
149                                              Short-chain fatty acids (SCFAs) have protective effects
150 e investigated the role of microbial-derived short-chain fatty acids (SCFAs) including acetate, butyr
151 hods that simulate physiological conditions, short-chain fatty acids (SCFAs) production, and a detail
152        Here, we show that microbiota-derived short-chain fatty acids (SCFAs) promote IL-22 production
153 lating concentrations of the microbe-derived short-chain fatty acids (SCFAs) propionate and butyrate
154 ns, giving rise to the in situ production of short-chain fatty acids (SCFAs) such as propionic and bu
155 ch as depletion of gut bacteria that produce short-chain fatty acids (SCFAs) through gut fermentation
156 t enrichment of selective bacteria producing short-chain fatty acids (SCFAs) was tested as a more tar
157                                ABSTRACT: The short-chain fatty acids (SCFAs), acetate, propionate and
158 nt capacity, phenolic profile, production of short-chain fatty acids (SCFAs), and gut microbiota comm
159 naerobic metabolism, like butyrate and other short-chain fatty acids (SCFAs), induce regulatory T cel
160 ng's mice/wild-type (WT) littermates, mainly short-chain fatty acids (SCFAs), ketones, and alcohols,
161          Here, we tested the hypothesis that short-chain fatty acids (SCFAs), key bioactive microbial
162                                              Short-chain fatty acids (SCFAs), such as acetate, propio
163                                              Short-chain fatty acids (SCFAs), such as butyrate, produ
164  particularly decreases in species producing short-chain fatty acids (SCFAs), such as butyrate.
165                                    Recently, short-chain fatty acids (SCFAs), which are generated by
166  beneficial bacteria in the colon to produce short-chain fatty acids (SCFAs), which are proposed to h
167 s in rats and in vitro hindgut production of short-chain fatty acids (SCFAs).
168 ichment increased the fecal concentration of short-chain fatty acids (SCFAs).
169                  This study aimed to deliver short-chain fatty acids (SCFAs, including propionic and
170 ntestinal regions by sensing lactate and the short-chain fatty acids acetate and butyrate and then al
171                          Levels of the fecal short-chain fatty acids acetate and caproate were reduce
172                     Fructose and exposure to short-chain fatty acids activate the Ack pathway, involv
173 and interleukin-1beta), rebalanced levels of short-chain fatty acids and bile acids, improved gut bar
174 ceramides, and an increased incorporation of short-chain fatty acids and dihydroxylated bases into in
175 at the microbiome, through the production of short-chain fatty acids and in particular, butyrate, is
176                                              Short-chain fatty acids and lactic acid with 2'-FL were
177 host features that are affected by microbial short-chain fatty acids and other metabolites.
178        Similarly, microbial products such as short-chain fatty acids and sphingolipids also influence
179 one deacetylase (HDAC) inhibitors, including short-chain fatty acids and suberanilohydroxamic acid (S
180 nd redox potential through the production of short-chain fatty acids and that the bacteria adjacent t
181                                              Short-chain fatty acids are metabolites generated by int
182                                              Short-chain fatty acids are processed from indigestible
183                       These results identify short-chain fatty acids as a missing link along the gut-
184 rences in microbe-associated amino acids and short-chain fatty acids between APOE genotypes.
185 ation for increased hepatic IR injury, fecal short-chain fatty acids butyrate and propionate levels w
186                                 Furthermore, short-chain fatty acids butyrate and propionate protect
187 erium in the human skin microbiome, produces short-chain fatty acids by glycerol fermentation that ca
188                       Evidence suggests that short-chain fatty acids can affect the epigenome through
189                                              Short-chain fatty acids derived from gut microbial ferme
190 disaccharides partially restored total fecal short-chain fatty acids from the level significantly rep
191 icrobial and anti-inflammatory activities of short-chain fatty acids have been previously well charac
192 uch uptake was correlated with appearance of short-chain fatty acids in basal side of the everted sac
193 y in mice, in part through the production of short-chain fatty acids leading to Treg cell development
194 pendent beta-oxidation of microbiota-derived short-chain fatty acids limits oxygen availability in th
195 ncreases the interest to elucidate impact of short-chain fatty acids on metabolism, obesity, and the
196 imethylamine/trimethylamine N-oxide pathway, short-chain fatty acids pathway, and primary and seconda
197                                 We show that short-chain fatty acids produced by P. acnes under envir
198 idium-histolyticum groups, and increased the short-chain fatty acids produced compared to the negativ
199 hat dietary fructose- and microbiota-derived short-chain fatty acids promote AckA-mediated acetic aci
200 tive concentrations of the anti-inflammatory short-chain fatty acids propionate, acetate and butyrate
201 D, soluble fiber is the best way to generate short-chain fatty acids such as butyrate, which has anti
202 of germ-free mice with bacteria that produce short-chain fatty acids suppresses cFos expression in th
203 ed with schizophrenia include differences in short-chain fatty acids synthesis, tryptophan metabolism
204 atty acid receptor 2 (FFAR2), a receptor for short-chain fatty acids that can affect the composition
205                 PB1 and H. biformis produced short-chain fatty acids that contributed to control prot
206 biome supplies essential metabolites such as short-chain fatty acids to skeletal muscle mitochondria,
207 d, little is known about the contribution of short-chain fatty acids to the adipogenic differentiatio
208 rogenes for which the production of branched short-chain fatty acids was knocked out, we discovered t
209 s collected from five different time points; short-chain fatty acids were also analyzed in allergic o
210                      Concentrations of fecal short-chain fatty acids were determined by using gas chr
211 costerone, microbiota composition, and cecal short-chain fatty acids were measured.
212 at plasma levels rather than fecal levels of short-chain fatty acids were relevant to inflammation an
213 iota-derived physiological modulators (e.g., short-chain fatty acids) and pathogenic mediators (e.g.,
214 olite pools (acylcarnitines, bile acids, and short-chain fatty acids), and levels of antibodies in ho
215 ble to identify dysregulation of bile acids, short-chain fatty acids, and cholesterol derivatives tha
216 egrading microbes, produced higher levels of short-chain fatty acids, and drove higher adiposity when
217 of evidence suggest that microbially derived short-chain fatty acids, and particularly butyrate, can
218 f trimethylamine and trimethylamine N-oxide, short-chain fatty acids, and secondary bile acids, that
219 hnospiraceae impact their hosts by producing short-chain fatty acids, converting primary to secondary
220                    Here, we demonstrate that short-chain fatty acids, fermentation products of the gu
221 on of resistant starch leads to increases in short-chain fatty acids, including the clinically benefi
222    The metabolites of colon microbiota, e.g. short-chain fatty acids, may influence the brain and beh
223 r 3 (FFA3, previously GPR41) is activated by short-chain fatty acids, mediates health effects of the
224  0.3 log(10) 16S rRNA gene copies per gram), short-chain fatty acids, microbiome, and ileitis severit
225     Here, we discuss microbial regulation of short-chain fatty acids, neurotransmitters, as-yet-uncha
226  chicken nutrition through the production of short-chain fatty acids, nitrogen recycling, and amino a
227  conferred by bacterial metabolites, such as short-chain fatty acids, or the modulation of immune res
228 t has esterase activity, with preference for short-chain fatty acids, particularly acetate, with high
229  these associations, typified by the role of short-chain fatty acids, products of fibre fermentation
230 ds/pathways, with specific attention paid to short-chain fatty acids, secondary bile acids, trimethyl
231 driven with proteins, carbohydrates or other short-chain fatty acids, systems fed with acetic acid re
232 r the direct conversion of lignocellulose to short-chain fatty acids, which included the funneling of
233 bundance and translocation of L. reuteri via short-chain fatty acids, which inhibited its growth.
234  sending one-carbon units into production of short-chain fatty acids.
235 acteroidetes, and marked reductions in cecal short-chain fatty acids.
236 ctional saturated long-chain fatty acids and short-chain fatty acids.
237 including anaerobic fermentation to generate short-chain fatty acids.
238 s was confirmed by the reduced production of short-chain fatty acids.
239 ng non-mannanolytic populations that produce short-chain fatty acids.
240 ta dysbiosis and increased the production of short-chain fatty acids.
241 t administration of a highly purified (>95%) short-chain galactooligosaccharide (GOS), designated "RP
242 icate that both long-chain glycopolymers and short-chain glycooligomers are capable of preventing vir
243  to form an autocatalytic set, through which short chains grow into longer chains that have particula
244 ntapeptide and heptaprenyl phosphate (C35-P, short-chain homolog of undecaprenyl phosphate, the endog
245 aerobically oxidize hydrothermally generated short-chain hydrocarbons.
246 unctional characterization of cDNAs encoding short-chain isoprenyl diphosphate synthases that control
247   Further highlighting the importance of the short-chain lipid geometry for late fission, we find tha
248 ransporter, Vrg4, revealed a requirement for short chain lipids and a marked difference in transport
249 dent lipid scramblase with a requirement for short chain lipids and calcium for robust activity.
250         A hitherto unobserved requirement of short-chain lipids in activating the transporter support
251 e elucidated by identifying the existence of short-chain molecular Se encapsulated inside the micropo
252                        However, then, how do short-chain molecules spontaneously grow longer?
253  mixtures are formed in aqueous solutions of short-chain n-alcohols (n </= 10), Tmix increases relati
254 transition temperatures (Tmix) observed when short-chain n-alcohols are incorporated into giant plasm
255  types of lipids, ratios of lipids, types of short-chain n-alcohols, and concentrations of n-alcohols
256                         It was observed that short chain oligosaccharides produce higher level of ace
257 glucosidic linkages from non-reducing end of short chain oligosaccharides, alkyl and aryl beta-D-gluc
258                 Here, we showed that certain short-chain oligosaccharides can bind to poliovirus but
259  content as sugars fructose and glucose, and short-chain organic acids.
260                Besides fluoride and sulfate, short-chain perfluorinated carboxylic acids (PFCAs) were
261 enting the environmental occurrence of ultra-short-chain perfluoroalkyl acids (PFAAs) are scarce and
262 ated on the fibers and then transformed into short-chain perfluoroalkyl acids.
263 e, 6:2 and 8:2 fluorotelomer sulfonates, and short chain perfluorocarboxylic acids.
264 PFCAs)) were decreased by >99.9% in 2 h, and short-chain PFAAs (<6C for perfluorocarboxylic acids (PF
265 f water-saturated products were primarily of short-chain PFAAs and increased with increasing PFAA con
266 the presence of high concentrations of ultra-short-chain PFAAs released into the environment from var
267 es and emphasize the large fraction of ultra-short-chain PFAAs to the total concentration of PFASs in
268                         In this study, ultra-short-chain PFAAs were analyzed in water connected to po
269                                        Ultra-short-chain PFAAs were detected in all samples at concen
270 onium bromide, a cationic surfactant) caused short-chain PFAAs, other than PFBA, to be removed to bel
271 ulted in the necessity for alternatives, and short-chained PFAAs and fluorotelomer-based surfactants
272 rn Sweden had been exposed to high levels of short-chain PFAS along with legacy PFAS (i.e., PFOA, PFH
273                                      PFBS, a short-chain PFAS compound that would presumably exhibit
274 ine) and to estimate serum half-lives of the short-chain PFAS together with legacy PFAS.
275 es; while in European and American countries short chain PFASs were detected, Asian countries still u
276 ton were calculated for six PFASs, including short chain PFASs.
277     Across all soils, the K(d) values of all short-chain PFASs (<=5 -CF2- moieties) were similar and
278                                     Emerging short-chain PFASs showed no temporal changes.
279 ound to be a host for a variety of long- and short-chain PFASs that lead to its overactivation.
280                                              Short-chain PFASs were less sensitive to solution pH tha
281                                          The short chain PFCAs detected suggest the occurrence of a s
282 ), while the reference area was dominated by short-chained PFCAs (>60%).
283 ily degraded, other structures, most notably short-chain PFSAs and fluorotelomer sulfonic acids (FTSs
284 s, we demonstrate that addition of exogenous short-chain PI(3,5)P2 to Vph1-containing vacuolar vesicl
285         We show here for the first time that short chain poly( N-isopropylacrylamide) (PNIPAM), one o
286                                       Herein short-chain poly(ethylene glycol) provided optimum extra
287 DDPA) with a disulfide bond (SS) extended by short-chain polyethylene glycol (PEG).
288 t is unknown whether spatial localization of short-chain polyP can accelerate clotting of flowing blo
289       Thus, sub-micromolar concentrations of short-chain polyP can accelerate clotting of flowing blo
290                                              Short-chain polyphosphate (polyP) is released from plate
291 polysulfide, and solid-state transition from short-chain polysulfide to magnesium sulfide occurs at l
292 d mitophagy predominantly exploits mono- and short-chain polyubiquitin, in which phosphorylated ubiqu
293 is suitable for conventional microscopy, the short-chain probe NR4A, owing to the reversible binding,
294 of the channel do not benefit the exhange of short-chain quinones, for which product dissociation may
295 chemicals, subdivided into three categories: short chain (SCCPs), medium chain (MCCPs), and long chai
296 o degrading large, amorphous structures into short, chain-shaped structures.
297 osis and more severe NASH, based on a set of short-chain TAGs and FFAs.
298                          In marked contrast, short-chain Vi (9.5 to 42.7 kDa) conjugates induced a re
299  neonatal mice, in which long-chain, but not short-chain, Vi conjugate induced late apoptosis of Vi-s
300 as observed for the NiS synthesized from the short chain xanthate complex.

 
Page Top